| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.3 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |